<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is an <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e> characterized by vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> or pregnancy morbidity </plain></SENT>
<SENT sid="1" pm="."><plain>Ocular involvement in APS includes a broad spectrum of manifestations involving anterior and posterior segment or the presence of neuroophthalmologic features </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0007634'>Nonarteritic anterior ischemic optic neuropathy</z:hpo> (NAION) is a very rare finding, and in this report a case having NAION as the prevailing sign of APS is presented </plain></SENT>
<SENT sid="3" pm="."><plain>A middle-aged women who presented with visual disturbances in her left eye (LE) and turned out to have the diagnosis of primary APS with the help of rheumatological investigations is discussed </plain></SENT>
<SENT sid="4" pm="."><plain>She was treated with oral steroids for NAION in her LE </plain></SENT>
<SENT sid="5" pm="."><plain>With systemic and rheumatological work-up, primary APS was diagnosed, and hydroxychloroquine, <z:chebi fb="0" ids="10034">coumadin</z:chebi>, and aspirin were started, after which she remained stable under control </plain></SENT>
<SENT sid="6" pm="."><plain>Due to the important diagnostic and therapeutic implications of APS, it should be considered in the differential diagnosis of NAION, particularly when the etiology is uncertain </plain></SENT>
</text></document>